F2 Capital I 2015 Ltd, 10% Owner at TCR2 THERAPEUTICS INC. (TCRR), sold 405,534 shares at $17.65 ($7.2M) on 2019-12-09, disclosed to the SEC on 2019-12-11.
Open-market sale of $7.2M TCRR by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $17.65 | 19,070 | $337K | 4.7% |
| 2 | $17.65 | 19,070 | $337K | 4.7% |
| 3 | $17.65 | 20,886 | $369K | 5.2% |
| 4 | $17.65 | 20,886 | $369K | 5.2% |
| 5 | $17.65 | 24,966 | $441K | 6.2% |
| 6 | $17.65 | 24,966 |
| $441K |
| 6.2% |
| 7 | $17.65 | 75,067 | $1.3M | 18.5% |
| 8 | $17.65 | 75,067 | $1.3M | 18.5% |
| 9 | $17.62 | 7,741 | $136K | 1.9% |
| 10 | $17.62 | 7,741 | $136K | 1.9% |
| 11 | $17.62 | 8,479 | $149K | 2.1% |
| 12 | $17.62 | 8,479 | $149K | 2.1% |
| 13 | $17.62 | 10,135 | $179K | 2.5% |
| 14 | $17.62 | 10,135 | $179K | 2.5% |
| 15 | $17.62 | 30,475 | $537K | 7.5% |
| 16 | $17.62 | 30,475 | $537K | 7.5% |
| 17 | $17.65 | 1,054 | $19K | 0.3% |
| 18 | $17.65 | 1,155 | $20K | 0.3% |
| 19 | $17.65 | 1,381 | $24K | 0.3% |
| 20 | $17.65 | 4,153 | $73K | 1.0% |
| 21 | $17.65 | 4,153 | $73K | 1.0% |
| Total | $17.64 avg | 405,534 | $7.2M | 100% |